Bradley Hanberry, PhD
Technical Director, Biorepository Core and Molecular Clinical Trials Laboratory
Dr. Hanberry is the Technical Director for the Biorepository Core and Molecular Clinical Trials Laboratory (MCTL). The Biorepository has been established to collect and distribute pediatric biological specimens for their future use in research at Emory University, Children’s Healthcare of Atlanta (CHOA), and collaborators outside of Emory University. The purpose of the CCTR Biorepository and MCTL are to support and compliment the research efforts of qualified investigators.
B. Hanberry, R. Berger, J. Zastre. High Dose Vitamin B1 Reduces Proliferation in Cancer Cell Lines Analogous to Dichloroacetate. Cancer Chemotherapy and Pharmacology. Cancer Chemother. Pharmacol. 2014 Mar;73(3):585-94.
J. Zastre, R. Sweet, B. Hanberry, S. Ye. Linking Vitamin B1 with Cancer Cell Metabolism. Cancer & Metabolism 2013, 1:16
Zastre JA, Hanberry BS, Sweet RL, McGinnis AC, Venuti KR, Bartlett MG, Govindarajan R (2013) Up-regulation of vitamin B1 homeostasis genes in breast cancer. The Journal of nutritional biochemistry 24 (9):1616-1624. doi:10.1016/j.jnutbio.2013.02.002
Babak Basiri, J. Michael Sutton, Bradley S. Hanberry, Jason A. Zastre and Michael G. Bartlett. Ion Pair Liquid Chromatography Method for the Determination of Thiamine (Vitamin B1) Homeostasis. Biomed Chromatogr. 28 Jun 2015.